Evidence map›Paper›PMID 27271344›Full record

ArticleScientific reports2016

Activation of the Renin-Angiotensin System Promotes Colitis Development.

Yongyan Shi, Tianjing Liu, Lei He, Urszula Dougherty, Li Chen, Sarbani Adhikari, Lindsay Alpert, Guolin Zhou, Weicheng Liu, Jiaolong Wang and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Role of local angiotensin II signaling in bladder function.American journal of physiology. Renal physiology · 2024
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Gut microbiota and renin-angiotensin system: a complex interplay at local and systemic levels.American journal of physiology. Gastrointestinal and liver physiology · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Yongyan ShiDepartment of Pediatrics, Shengjing Hospital, China Medical University, Shenyang, Liaoning, 110004, China.
Tianjing LiuDepartment of Pediatrics, Shengjing Hospital, China Medical University, Shenyang, Liaoning, 110004, China.
Lei HeDepartment of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
Urszula DoughertyDepartment of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
Li ChenDepartment of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
Sarbani AdhikariDepartment of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
Lindsay AlpertDepartment of Pathology, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
Guolin ZhouDepartment of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
Weicheng LiuDepartment of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
Jiaolong WangDepartment of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
Dilip K DebDepartment of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
John HartDepartment of Pathology, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
Shu Q LiuDepartment of Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA.
John KwonDepartment of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
Joel PekowDepartment of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
David T RubinDepartment of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
Qun ZhaoDepartment of Pediatrics, Shengjing Hospital, China Medical University, Shenyang, Liaoning, 110004, China.
Marc BissonnetteDepartment of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
Yan Chun LiDepartment of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
University of Chicago · USChina Medical University · CNNorthwestern University · US

Funding

ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI ABADIE, VALERIE · 1990 to 2025
$29.8M
(PQA1) Mechanism of Vitamin D Chemoprevention Against Colon CancerR01CA180087 · NCI · UNIVERSITY OF CHICAGO · PI LI, YAN CHUN · 2013 to 2016
$1.7M
Roles of EGFR and miR-143/miR-145 in Western diet-promoted colonic tumorigenesisR01CA164124 · NCI · UNIVERSITY OF CHICAGO · PI BISSONNETTE, BRUCE MARC · 2012 to 2016
$1.6M
Novel microRNA regulatory networks predictive of colon carcinogenesis in IBDK08DK090152 · NIDDK · UNIVERSITY OF CHICAGO · PI PEKOW, JOEL · 2012 to 2016
$732k
NCI NIH HHS R01 CA164124NCI NIH HHS R01 CA180087NIDDK NIH HHS K08 DK090152NIDDK NIH HHS P30 DK042086
6 · The paper itself

Abstract

The renin-angiotensin system (RAS) plays pathogenic roles in renal and cardiovascular disorders, but whether it is involved in colitis is unclear. Here we show that RenTgMK mice that overexpress active renin from the liver developed more severe colitis than wild-type controls. More than 50% RenTgMK mice died whereas all wild-type mice recovered. RenTgMK mice exhibited more robust mucosal TH17 and TH1/TH17 responses and more profound colonic epithelial cell apoptosis compared to wild-type controls. Treatment with aliskiren (a renin inhibitor), but not hydralazine (a smooth muscle relaxant), ameliorated colitis in RenTgMK mice, although both drugs normalized blood pressure. Chronic infusion of angiotensin II into wild-type mice mimicked the severe colitic phenotype of RenTgMK mice, and treatment with losartan [an angiotensin type 1 receptor blocker (ARB)] ameliorated colitis in wild-type mice, confirming a colitogenic role for the endogenous RAS. In human biopsies, pro-inflammatory cytokines were suppressed in patients with inflammatory bowel disease who were on ARB therapy compared to patients not receiving ARB therapy. These observations demonstrate that activation of the RAS promotes colitis in a blood pressure independent manner. Angiotensin II appears to drive colonic mucosal inflammation by promoting intestinal epithelial cell apoptosis and mucosal TH17 responses in colitis development.

Indexed as

AmidesAngiotensin IIAngiotensin II Type 1 Receptor BlockersAnimalsApoptosisColitisColonEpithelial CellsFumaratesHumansHydralazineInflammatory Bowel DiseasesLosartanMiceMice, TransgenicReceptor, Angiotensin, Type 1aliskirenAmidesAngiotensin IIAngiotensin II Type 1 Receptor BlockersFumaratesHydralazineLosartanReceptor, Angiotensin, Type 1Renin

Identifiers

PMID27271344
PMCPMC4897651
OpenAlexW2417290036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.